145 related articles for article (PubMed ID: 9777791)
1. Pharmacokinetics and safety review of tazarotene.
Marks R
J Am Acad Dermatol; 1998 Oct; 39(4 Pt 2):S134-8. PubMed ID: 9777791
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and safety of tazarotene.
Menter A
J Am Acad Dermatol; 2000 Aug; 43(2 Pt 3):S31-5. PubMed ID: 10898827
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacokinetics and drug metabolism of tazarotene: a novel topical treatment for acne and psoriasis.
Tang-Liu DD; Matsumoto RM; Usansky JI
Clin Pharmacokinet; 1999 Oct; 37(4):273-87. PubMed ID: 10554045
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of tazarotene and acitretin in psoriasis.
Heath MS; Sahni DR; Curry ZA; Feldman SR
Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):919-927. PubMed ID: 30134735
[TBL] [Abstract][Full Text] [Related]
5. The role of tazarotene in the treatment of psoriasis.
Marks R
Br J Dermatol; 1999 Apr; 140 Suppl 54():24-8. PubMed ID: 10731131
[TBL] [Abstract][Full Text] [Related]
6. Clinical safety of tazarotene in the treatment of plaque psoriasis.
Marks R
J Am Acad Dermatol; 1997 Aug; 37(2 Pt 3):S25-32. PubMed ID: 9270553
[TBL] [Abstract][Full Text] [Related]
7. Strategies to optimize efficacy, duration of remission, and safety in the treatment of plaque psoriasis by using tazarotene in combination with a corticosteroid.
Lebwohl M
J Am Acad Dermatol; 2000 Aug; 43(2 Pt 3):S43-6. PubMed ID: 10898829
[TBL] [Abstract][Full Text] [Related]
8. Genital ulcers in a psoriasis patient using topical tazarotene.
Wollina U
Br J Dermatol; 1998 Apr; 138(4):713-4. PubMed ID: 9640392
[No Abstract] [Full Text] [Related]
9. Tazarotene combination treatments in psoriasis.
Guenther L
J Am Acad Dermatol; 2000 Aug; 43(2 Pt 3):S36-42. PubMed ID: 10898828
[TBL] [Abstract][Full Text] [Related]
10. Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis.
Lebwohl MG; Breneman DL; Goffe BS; Grossman JR; Ling MR; Milbauer J; Pincus SH; Sibbald RG; Swinyer LJ; Weinstein GD; Lew-Kaya DA; Lue JC; Gibson JR; Sefton J
J Am Acad Dermatol; 1998 Oct; 39(4 Pt 1):590-6. PubMed ID: 9777766
[TBL] [Abstract][Full Text] [Related]
11. Tazarotene 0.1% gel in combination with mometasone furoate cream in plaque psoriasis: a photographic tracking study.
Poulin YP
Cutis; 1999 Jan; 63(1):41-8. PubMed ID: 9951595
[TBL] [Abstract][Full Text] [Related]
12. Tazarotene in combination with phototherapy.
Koo JY
J Am Acad Dermatol; 1998 Oct; 39(4 Pt 2):S144-8. PubMed ID: 9777793
[TBL] [Abstract][Full Text] [Related]
13. Tazarotene--first of a new generation of receptor-selective retinoids.
Chandraratna RA
Br J Dermatol; 1996 Oct; 135 Suppl 49():18-25. PubMed ID: 9035701
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of tazarotene cream 0.1% after a single dose and after repeat topical applications at clinical or exaggerated application rates in patients with acne vulgaris or photodamaged skin.
Yu Z; Sefton J; Lew-Kaya D; Walker P; Yu D; Tang-Liu DD
Clin Pharmacokinet; 2003; 42(10):921-9. PubMed ID: 12885265
[TBL] [Abstract][Full Text] [Related]
15. Tazarotene: the first receptor-selective topical retinoid for the treatment of psoriasis.
Chandraratna RA
J Am Acad Dermatol; 1997 Aug; 37(2 Pt 3):S12-7. PubMed ID: 9270551
[TBL] [Abstract][Full Text] [Related]
16. The pathogenesis of psoriasis and the mechanism of action of tazarotene.
Duvic M; Asano AT; Hager C; Mays S
J Am Acad Dermatol; 1998 Oct; 39(4 Pt 2):S129-33. PubMed ID: 9777790
[TBL] [Abstract][Full Text] [Related]
17. Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis.
Lebwohl M; Ast E; Callen JP; Cullen SI; Hong SR; Kulp-Shorten CL; Lowe NJ; Phillips TJ; Rosen T; Wolf DI; Quell JM; Sefton J; Lue JC; Gibson JR; Chandraratna RA
J Am Acad Dermatol; 1998 May; 38(5 Pt 1):705-11. PubMed ID: 9591815
[TBL] [Abstract][Full Text] [Related]
18. Rational design of receptor-selective retinoids.
Chandraratna RA
J Am Acad Dermatol; 1998 Oct; 39(4 Pt 2):S124-8. PubMed ID: 9777789
[TBL] [Abstract][Full Text] [Related]
19. Disposition and biotransformation of the acetylenic retinoid tazarotene in humans.
Attar M; Yu D; Ni J; Yu Z; Ling KH; Tang-Liu DD
J Pharm Sci; 2005 Oct; 94(10):2246-55. PubMed ID: 16136553
[TBL] [Abstract][Full Text] [Related]
20. Determination of clobetasol propionate, tazarotene and tazarotenic acid in Bama mini-pig skin by UPLC-MS/MS: Application to pharmacokinetic and drug-drug interaction studies.
Lu YT; Guan R; Zheng JR; Hang TJ; Song M
J Pharm Biomed Anal; 2020 Jul; 186():113322. PubMed ID: 32380355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
